MBX Biosciences, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Operating income | -$98.1 | -$68.2 | -$35.3 | — |
| Net income | -$87.0 | -$61.9 | -$32.6 | — |
| Cash Flow Statement | ||||
| Free cash flow | -$81.9 | -$55.6 | -$32.1 | — |
| Share repurchases | $<0.1 | — | — | — |
Shares outstanding 48.2M · Free float 61.1%
Annual filing data through FY ended December 31, 2025; float as of October 4, 2026.